given clearer guidance on how to avoid bleeding risks when using
Boehringer Ingelheim's new stroke prevention pill Pradaxa,
European regulators said on Friday.
Saturday, May 26, 2012
EU body wants new guidance on Boehringer clot drug
LONDON, May 25 (Reuters) - Doctors and patients should be
given clearer guidance on how to avoid bleeding risks when using
Boehringer Ingelheim's new stroke prevention pill Pradaxa,
European regulators said on Friday. 
given clearer guidance on how to avoid bleeding risks when using
Boehringer Ingelheim's new stroke prevention pill Pradaxa,
European regulators said on Friday.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment